Zhejiang Rongyao Biotech

Company snapshot

Zhejiang Rongyao Biotech Co., Ltd. is located in the Taizhou Bay Economic and Technological Development Zone which is a state-level economic and technological development zone, an innovation-driven pharmaceutical company. Its business covers pharmaceutical API and intermediate, veterinary drug API and intermediate, CDMO, etc. We have established a standardized production manufacturing and quality

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Zhejiang Rongyao Biotech. Not investment advice.

• What is Zhejiang Rongyao Biotech?

  Zhejiang University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Colorectal Neoplasms, Borderline Resectable Pancreatic Adenocarcinoma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity fr

• Is Zhejiang Rongyao Biotech publicly traded?

  Zhejiang Rongyao Biotech appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Zhejiang Rongyao Biotech develop or market?

  We link 3 drug profile(s) where Zhejiang Rongyao Biotech is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/zhejiang-university#company-drugs.

• What are the latest developments for Zhejiang Rongyao Biotech?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Zhejiang Rongyao Biotech focus on?

  Zhejiang Rongyao Biotech focuses on Colorectal Neoplasms, Borderline Resectable Pancreatic Adenocarcinoma based on our analysis of their pipeline programs and drug development activities.